VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Vireo Growth Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026
- Market cap
- $406.23M
- P/E (TTM)
- –
- Dividend yield
- –
Vireo Growth Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail | $290.60M | $219.93M | $151.30M | $95.09M | $79.14M | $79.53M | $80.02M | $80.42M | $76.75M | $73.62M | $70.04M | $66.28M | 82.9% | +267.2% |
| Wholesale | $59.83M | $48.84M | $37.94M | $27.66M | $20.66M | $19.85M | $18.52M | $17.62M | $16.38M | $14.51M | $12.96M | $10.90M | 17.1% | +189.6% |
By region
From the segment and revenue-disaggregation notes of Vireo Growth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.